![]() 230000014509 gene expression Effects 0.000 claims description 25.125000003275 alpha amino acid group Chemical group 0.000 claims description 26.102000002262 Thromboplastin Human genes 0.000 claims description 100.108010000499 Thromboplastin Proteins 0.000 claims description 100.239000008194 pharmaceutical composition Substances 0.000 claims abstract description 16.239000000701 coagulant Substances 0.000 claims abstract description 24.238000000034 method Methods 0.000 claims abstract description 30.239000000203 mixture Substances 0.000 claims abstract description 43.108090000623 proteins and genes Proteins 0.000 claims abstract description 64.102000004169 proteins and genes Human genes 0.000 claims abstract description 64.108090001123 antibodies Proteins 0.000 claims abstract description 73.102000004965 antibodies Human genes 0.000 claims abstract description 73.206010028980 Neoplasm Diseases 0.000 claims abstract description 148.231100000844 hepatocellular carcinoma Toxicity 0.000 title abstract description 69.206010073071 Hepatocellular carcinoma Diseases 0.000 title claims abstract description 72.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US201361904951P priority Critical Priority to US61/904.951 priority Application filed by China Synthetic Rubber Corp filed Critical China Synthetic Rubber Corp Publication of BR102014029197A2 publication Critical patent/BR102014029197A2/en Publication of BR102014029197A8 publication Critical patent/BR102014029197A8/en Publication of BR102014029197B1 publication Critical patent/BR102014029197B1/en Links ( en Inventor Kuo-Jang Kao Yun-Hsin Wang Original Assignee China Synthetic Rubber Corp Priority date (The priority date is an assumption and is not a legal conclusion.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |